Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rozencweig

Showing results (81-90 of 150) with videos related to

Pageof 15
Sort By:
Cancer Treatment Reviews|March 1, 1989
Megestrol acetate: clinical experienceL Schacter, M Rozencweig, R Canetta, et al.
The New England Journal of Medicine|February 24, 1977
Tuftsin - unimportant or forgotten?S W Mikulski, D D Von Hoff, M Rozencweig, et al.
Cancer Treatment Reports|March 1, 1985
Phase II evaluation of bisantrene in metastatic breast cancerF Cavalli, B Gerard, W ten Bokkel Huinink, et al.
Archiv Fur Geschwulstforschung|January 1, 1978
Current trends and prospects in surgical adjuvant trialsM Rozencweig, D D von Hoff, A C Louie, et al.
Cancer|March 1, 1978
The use of peritoneoscopy in the detection of liver metastasesH Bleiberg, M Rozencweig, M Mathieu, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
In vitro growth of human malignancies in a cloning assayM Rozencweig, V Hofmann, C Sanders, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1982
N-(phosphonacetyl)-L-aspartate (PALA) in advanced malignant melanoma: a phase II trial of the EORTC Malignant Melanoma Cooperative GroupU R Kleeberg, J H Mulder, P Rümke, et al.
Seminars in Oncology|December 1, 1990
Overview of hormonal therapy in advanced breast cancerL P Schacter, M Rozencweig, R Canetta, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
N-(Phosphonacetyl)-L-aspartate (PALA): current statusM Rozencweig, R Abele, M Piccart, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1981
Absorption of m-AMSA and its biliary metabolites from the rat small intestineP E Gormley, D Shoemaker, M Rozencweig, et al.
Pageof 15

Showing results (81-90 of 150) with videos related to

Sort By:
Pageof 15
Cancer Treatment Reviews|March 1, 1989
Megestrol acetate: clinical experienceL Schacter, M Rozencweig, R Canetta, et al.
The New England Journal of Medicine|February 24, 1977
Tuftsin - unimportant or forgotten?S W Mikulski, D D Von Hoff, M Rozencweig, et al.
Cancer Treatment Reports|March 1, 1985
Phase II evaluation of bisantrene in metastatic breast cancerF Cavalli, B Gerard, W ten Bokkel Huinink, et al.
Archiv Fur Geschwulstforschung|January 1, 1978
Current trends and prospects in surgical adjuvant trialsM Rozencweig, D D von Hoff, A C Louie, et al.
Cancer|March 1, 1978
The use of peritoneoscopy in the detection of liver metastasesH Bleiberg, M Rozencweig, M Mathieu, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1984
In vitro growth of human malignancies in a cloning assayM Rozencweig, V Hofmann, C Sanders, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1982
N-(phosphonacetyl)-L-aspartate (PALA) in advanced malignant melanoma: a phase II trial of the EORTC Malignant Melanoma Cooperative GroupU R Kleeberg, J H Mulder, P Rümke, et al.
Seminars in Oncology|December 1, 1990
Overview of hormonal therapy in advanced breast cancerL P Schacter, M Rozencweig, R Canetta, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
N-(Phosphonacetyl)-L-aspartate (PALA): current statusM Rozencweig, R Abele, M Piccart, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1981
Absorption of m-AMSA and its biliary metabolites from the rat small intestineP E Gormley, D Shoemaker, M Rozencweig, et al.
Pageof 15